Precigen

Precigen is a biopharmaceutical company focused on discovery and clinical-stage development, utilizing precision technologies to advance next-generation gene and cell therapies targeting the most urgent and difficult-to-treat diseases in our core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. Our technologies enable us to find innovative solutions for affordable biotherapeutics in a controlled manner. Precigen acts as an innovation engine, advancing preclinical and clinical pipelines of differentiated and unique therapies toward clinical proof-of-concept and commercialization.